Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP732252.RAc2UIYhajeC86j9enwDk24u1rjCfUhLLgzH7FTu_x-nc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP732252.RAc2UIYhajeC86j9enwDk24u1rjCfUhLLgzH7FTu_x-nc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP732252.RAc2UIYhajeC86j9enwDk24u1rjCfUhLLgzH7FTu_x-nc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP732252.RAc2UIYhajeC86j9enwDk24u1rjCfUhLLgzH7FTu_x-nc130_provenance.
- NP732252.RAc2UIYhajeC86j9enwDk24u1rjCfUhLLgzH7FTu_x-nc130_assertion description "[TOP2A aberrations (amplification, deletion) are found in up to approximately 30-90 % of HER2 amplified breast cancer and amplifications are more common than deletions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732252.RAc2UIYhajeC86j9enwDk24u1rjCfUhLLgzH7FTu_x-nc130_provenance.
- NP732252.RAc2UIYhajeC86j9enwDk24u1rjCfUhLLgzH7FTu_x-nc130_assertion evidence source_evidence_literature NP732252.RAc2UIYhajeC86j9enwDk24u1rjCfUhLLgzH7FTu_x-nc130_provenance.
- NP732252.RAc2UIYhajeC86j9enwDk24u1rjCfUhLLgzH7FTu_x-nc130_assertion SIO_000772 19365520 NP732252.RAc2UIYhajeC86j9enwDk24u1rjCfUhLLgzH7FTu_x-nc130_provenance.
- NP732252.RAc2UIYhajeC86j9enwDk24u1rjCfUhLLgzH7FTu_x-nc130_assertion wasDerivedFrom befree-2016 NP732252.RAc2UIYhajeC86j9enwDk24u1rjCfUhLLgzH7FTu_x-nc130_provenance.
- NP732252.RAc2UIYhajeC86j9enwDk24u1rjCfUhLLgzH7FTu_x-nc130_assertion wasGeneratedBy ECO_0000203 NP732252.RAc2UIYhajeC86j9enwDk24u1rjCfUhLLgzH7FTu_x-nc130_provenance.
- befree-2016 importedOn "2016-02-19" NP732252.RAc2UIYhajeC86j9enwDk24u1rjCfUhLLgzH7FTu_x-nc130_provenance.